Industrial Microbiology Market: Reaction Consumables Segment is Expected to Dominate the Market

The global industrial microbiology market is expected to witness a y-o-y growth of 6.7% in 2016 over 2015 and reach US$ 9.46 Bn in revenues. North America will continue to be the most lucrative market, accounting for over 25% of the market share.

In addition to increase in food consumption, rising emphasis on industrial food safety is predicted to fuel market growth. Wide-ranging applications of industrial microbiology and biotechnology in various verticals, including agriculture, pharmaceuticals, and food & beverages are also expected to play a key role in driving the growth of the market. Consumer preference towards nutraceuticals, increasing automation, and strategic partnerships across the healthcare value chain are other key drivers for industrial microbiology market.

Manufacturing of sterile products specifically demands higher costs in order to maintain aseptic conditions, which remains an abiding challenge for the market. Growing demand for advanced technology is also expected to hamper market growth.

Apart from applications in fermentation of wine, beer, and cheese, the use of industrial microorganisms in syrup formulation is also gaining traction. Other influential trends include use in bioremediation processes, manufacturing of empty capsules, and preparation of genetically modified food products.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1743

On the basis of product type, the global industrial microbiology market is segmented into reaction consumables, equipment & systems, and laboratory supply. While the reaction consumables segment is expected to dominate the market with over 60% of the total market share in 2016, equipment and systems segment’s revenue share will be over 25%. By test type, sterility testing and microbial limit testing are projected to collectively contribute around 60% to the total market share.

The pharmaceuticals & biotechnology segment will remain the largest end-use segment in the industrial microbiology segment, owing to rising novel drug development practices.

America will remain the largest and fastest growing market due to easier product approval processes. The U.S., a leading market for pharmaceuticals, will continue to dominate the North American market, accounting for over three-fourths revenue shares in 2016. Europe will maintain its position as the second largest market for industrial microbiology.

Speak To Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1743

Thermo Fisher Scientific Inc., and bioMérieux SA remained the two largest players, accounting for a market share of 34.8% in 2015 (with respect to reaction consumables segment & reagent kits). Strong product portfolio, strategic R&D, strong market channels, prominent market presence, and sizeable presence in developing regions remain key strengths of these market leaders. Other leading players in the market include Merck KGaA, Qiagen, Sartorius AG, Bio-Rad Laboratories, Inc., and Becton, Dickinson and Company.

Long-term Outlook: The global industrial microbiology market is expected to expand at a CAGR of 7.1% over the forecast period, 2016-2024. FMI reports growing opportunities in the market, especially for pharmaceutical and biotechnology companies.

Advertisements

India Will Maintain Its Position As The Leading APAC Home Wi-Fi Security Solutions Market

APAC home Wi-Fi security solutions market revenue is expected to expand at a year-over-year rate of 9.3% in 2016 over 2015 and surpass US$ 8,824.9 in revenues. India, the largest market for home Wi-Fi security solutions in APAC, will continue to witness strong growth rates in 2016.

Growing subscriber base for internet usage and smart devices will continue to fuel the growth of Wi-Fi security solutions market in the region. In addition, increasing internet penetration, and development of cyber-crime networks and commercial-scale toolkits that create malignant malware are influencing individuals to install home Wi-Fi security solutions. Mounting concerns over growing cybercrimes are also anticipated to play a key role in driving the growth of the home Wi-Fi security solutions market in APAC.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-ap-1723

On the basis of home network architecture, Wi-Fi routers will dominate market revenues, accounting for a 47.7% share in 2016. Modem and router (combo) devices will grow in popularity owing to their advantages, such as lower space requirement and necessity of fewer cables. Constant innovation in functionality of Wi-Fi router services and production of cost-effective devices is expected to further drive the growth of the market. By components, the hardware segment will continue to account for the highest share in terms of revenue.

India will maintain its position as the leading APAC home Wi-Fi security solutions market, accounting for over 74.5% revenue share in 2016. Affordable service availability and pervasive wireless connectivity will support the growth of the market in the country. Malaysia and Indonesia will also exhibit healthy growth rates owing to an increasing adoption of cloud in IoT services and growing market for M2M communication in these countries.

Speak To Analyst@ http://www.futuremarketinsights.com/askus/rep-ap-1723

Key participants identified in the APAC home Wi-Fi security solutions market include Koalasafe Inc., Keezel, Securifi, Cujo LLC, eero Inc., and Luma Home Inc.

Long-term Outlook: The APAC home Wi-Fi security solutions market is expected to expand at a CAGR of 12.7% during the forecast period 2016-2026. India will continue to witness exponential growth during the forecast period.

Platelet Rich Plasma (PRP) Market: Orthopaedic Surgery will be the Largest Application Segment

The global platelet rich plasma (PRP) market is projected to witness a year-over-year growth rate of 11.8% in 2016 over 2015 to reach US$ 224.0 Mn in revenues. Increase in the number of patients suffering from orthopaedic injuries and widening application area of PRP in different surgeries is likely to catalyse the market the growth. Use of PRP therapy in treating sports injuries is also anticipated to boost the growth of the market.

By type, pure PRP is likely to dominate product segment in 2016 with the revenue share of about 65%. The segment is also forecast to dominate other application segments through the forecast period. This segment is estimated to witness a year-over-year growth of 11.4% to reach US$ 144.3 Mn in revenues in 2016. Pure PRF/Leukocyte rich PRF segment is projected to register impressive year-over-year growth of 15.5% in 2016.

By origin, autologous segment will continue to be the prominent segment in 2016, accounting for three fourth of total revenue generated in the year. This segment will witness a year-over-year growth of 11.0% to reach US$ 169.1 Mn in revenues in 2016. Autologous segment among other PRP origins is slated to reflect moderate market performance in 2016, is likely to lose market share to allogenic PRP over next four to five years. Allogenic segment is also projected to register an impressive year-over-year growth of nearly 15% in 2016.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1722

Examining the PRP demand statistics from different surgeries clearly forebodes the dominance of orthopaedic surgery. Currently, orthopaedic surgery is the leading application segment accounting for a revenue share of over 35% in 2016.Orthopaedic surgery is followed by cosmetic surgery, which is estimated to be valued over US$ 50 Mn in 2016. Cosmetic surgery will continue to remain the second-largest application segment, with total revenues expected to reach US$ 59.6 Mn by 2016 end.

In terms of geography, North America, being the advanced market, characterized by early adopters of PRP based therapies. The market in North America is estimated to increase by 11.4% in 2016 to reach very close to US$ 120 Mn. Growth of the market in this region is supported by increasing number of cosmetic and orthopaedic surgeries. Moreover, the region is home to some of the most prominent players operating in the PRP market and hence awareness among patients is also high. Awareness among healthcare community as well as patients is also anticipated to fuel the growth of in North American market.

Adoption of PRP therapy in Asia Pacific is growing at a brisk pace, fuelled by the region’s status as an epicentre of medical tourism. The region has a high geriatric population, and adoption of PRP therapy has witnessed a surge in the recent past. The APAC plasma therapy market is anticipated to increase at a year-on-year growth rate of 16.1% in 2016 to reach US$ 40.5 Mn in revenues.

Speak To Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1722

Key players operating in the global platelet rich plasma market are Harvest Technologies Corp., Biomet, Inc., Arthrex, Inc. and Arteriocyte Medical Systems, Inc. Dr. PRP America, Cesca Therapeutics, Inc., and Regen Lab SA.

Long-term Outlook: The global platelet rich plasma market is projected to increase at a CAGR of over 12.0% during the forecast period from 2016-2026. North America is forecast to dominate the global market throughout the forecast period, whereas orthopaedic surgery will be the largest application segment.

Saudi Arabia Pharmaceutical Market: Retail Pharmacies will Continue to Account For 80% Market Share

The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia. In 2016, the Saudi Arabia pharmaceutical market is anticipated to procure value worth US$ 5,209.5 Mn at a y-o-y growth of 6.0 % over 2015. The mounting demand for branded drug products will continue to incite the growth of the Saudi Arabian pharmaceutical market in 2016.

The demand for pharmaceuticals in Saudi Arabia is expected to register substantial growth owing to the increasing penetration of health insurance companies and the rising incidence rate of non-communicable diseases. Furthermore, the exceptional rise in the per capita income of Saudi Arabia is also expected to foster the demand for branded pharmaceutical drugs. Another key factor driving the growth of the pharmaceutical market in Saudi Arabia is the country’s strategic move to allow 100% FDI in the pharmaceuticals sector. Although, the shortage of profound indigenous research capacity in the pharmaceutical industry and the delayed registration of drug and medicine patents is expected to limit the expansion of the market in 2016 and beyond.

Based on the product type, the pharmaceutical market in Saudi Arabia is expected to witness an upsurge in the prescription-type branded drug products. In terms of market value, the branded drugs are estimated to reach US$ 2,760.8 Mn by 2016-end. The demand for generic drugs is projected to secure steady growth, attributing to the insisting promotion of generic drug adoption by healthcare insurance providers.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gc-1733

On the basis of the diseases, the pharmaceutical drugs used for treatment of cardiovascular diseases will continue exhibiting robust growth in 2016. The demand for cardiovascular medications will continue to surge due to the prominence of circulatory disorders in Saudi Arabia. Additionally, the rising prevalence of disorders related to body sugar levels is expected to make diabetes a rapidly growing disease-based sub-segment in the Saudi Arabia pharmaceutical market.

The pharmaceutical market in Saudi Arabia is also segmented on the basis of distribution channel, where retail pharmacies will continue to account for 80% market share compared to hospital pharmacies. The westernised modernisation of retail pharmacies in Saudi Arabia has led to the availability of a wide range drugs and medicinal products, thereby attaining a considerable growth in the retail pharmacy sub-segment in 2016 and further.

The rising resource potential in Saudi Arabia is projected to positively reform the production environment for pharmaceutical manufacturers. In order to expand the market’s size, structuring alliances with well-established native companies is predicted to be a key strategy for global pharmaceutical leaders. The key players in the Saudi Arabia pharmaceutical market include Novartis AG, SPIMACO, Pfizer Inc., and Glaxosmithkline plc. Jamjoom Pharma, and Tabuk Pharmaceutical Manufacturing Co. among others.

Speak To Analyst@ http://www.futuremarketinsights.com/askus/rep-gc-1733

Long-term Outlook: The Saudi Arabia pharmaceutical market is expected to expand at a CAGR of 9.0% over the forecast period 2016-2026. In terms of market value, the pharmaceutical market in Saudi Arabia is estimated to be worth US$ 12,281.4 Mn by the end of forecast period.

Non-Halogenated Flame Retardants Market worth US$ 4.5 Bn by 2025

Future Market Insights (FMI) delivers key insights on the global non-halogenated flame retardants market in its latest report titled “Non-Halogenated Flame Retardants (NHFR) Market: Global Industry Analysis and Opportunity Assessment 2015-2025”.

In terms of value, the global non-halogenated flame retardants market is projected to expand at a CAGR of 6.4% during the forecast period.

NHFR are flame retardant compounds that do not contain any halogen. These are more environment friendly than their halogenated counterparts. These compounds find application in plastics, rubber, and textiles materials. Among these, they find largest application in plastics.

Growing use of plastics in the construction industry, driven by rising urbanisation is propelling demand for NHFR worldwide. NHFR are widely used in automotive plastics, which significantly increases its demand from the transportation and automobile industry across the globe.

Rising concerns regarding the environmental impact of halogenated flame retardants is fuelling growth of the non-halogenated flame retardants market. Non-halogenated flame retardants can be recycled and also produce relatively low and non-toxic smoke as compared to its other counterparts.

Implementation of stringent environmental regulations across the globe is encouraging adoption of non-halogenated flame retardants, especially in the electrical & electronics industry, which is expected to be the fastest growing segment in the market over the forecast period.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1165

Non-halogenated Flame Retardants Market Segmentation

The global non-halogenated flame retardants market is segmented on the basis of product type, end-use industry, application and region.

On the basis of product type, the global NHFR market is segmented into metal hydroxide based, phosphorous based, nitrogen based and others product segments.

Among product types, the phosphorous based segment accounted for the largest value share in the global non-halogenated flame retardants market in 2014, followed by the metal oxide based and nitrogen-based segments respectively. The phosphorous-based segment is projected to remain the largest segment throughout the forecast period, creating an incremental $ opportunity of US$ 1,117.2 Mn between 2015 and 2025.

On the basis of end-use industry, the market is segmented into electrical and electronics, automotive, building and construction and others.

Building & construction industry accounted for the largest end-use industry segment in 2014, followed by electrical & electronics and automotive & transportation segments respectively. However, electrical & electronics is projected to emerge as the largest end-use industry segment by the end of the forecast period. The electrical & electronics segment is expected to create incremental $ opportunity of US$ 699.7 Mn between 2015 and 2025.

Application-wise, the NHFR market is segmented into polyolefin (PO), epoxy, unsaturated polyester (UPE), rubber, polyvinyl chloride (PVC), polyurethane (PU), styrenics, engineering thermoplastics (ETP) and others.

The report also offers in-depth information about the market across seven major regions, namely, North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Middle East & Africa and Japan.

Speak To Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1165

In 2014, North America accounted for the largest market value share in the global NHFR market, followed by Western Europe and APEJ respectively. Developed regions namely, North America, Western Europe and Japan collectively accounted for approximately three-fourth value share of the overall market in 2014. APEJ is expected to emerge as the fastest growing market for non-halogenated flame retardants over the forecast period.

Non-halogenated Flame Retardants Market: Leading Companies

The key players in the non-halogenated flame retardants market that have been covered in this study are Clariant International Limited, Albemarle Corporation, Israel Chemical Limited, Italmatch Chemicals S.p.A, Chemtura Corporation, Nabaltec AG, FRX Polymer Inc, Huber Engineered Material, Amfine Chemical Corporation and THOR Group Ltd. accounted for the largest market share in the global non-halogenated flame retardant market by the end of financial year 2014–2015.

Protein A Resins Market Expected to Witness a CAGR of 8.2% through 2026

The global protein A resin market is expected to increase at a y-o-y growth rate of over 7% and reach US$ 380.4 Mn in revenues in 2016. North America, Asia Pacific excluding Japan (APEJ), and Western Europe will collectively account for nearly 70% revenue share of the market in 2016. Increasing process efficiency, growing preference for e-distribution channels and strategic integration of supply chains are some of the major trends impacting the growth of the global protein A resin market.

The wide range of therapeutic applications of monoclonal antibodies will lead to more research and improved focus on biotechnology sector, resulting into increasing demand for protein A resins. Favourable government policies – in terms of formulation of suitable policies for startups and administration of funding for development of next-gen medical products — are expected to play an important role in driving growth. Development of cost-effective protein A resin is also expected to boost the growth of the market in 2016 and beyond. In contrast, efficacy of alternate purification methods of monoclonal antibodies and high cost (US$ 15,000 – US$ 16,000 per litre) will continue to pose challenges for widespread adoption.

On the basis of product-type, natural protein A resins are expected to outsell recombinant protein A resins. Demand for natural and recombinant protein A resins will be fuelled by the favourable results of the therapeutic uses of monoclonal antibodies. The recombinant protein A resins segment is expected to surpass US$ 135 Mn in revenues in 2016, up from nearly US$ 125 Mn in 2015.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1720

Agarose-based protein A resins will remain the largest segment by matrix type, accounting for over 85% revenue share of the market in 2016. Demand for glass/silica-based and organic polymer-based protein A resins will decline, owing to higher adoption of agarose-based protein A resins.

The antibody purification applications of protein A resins will continue to hold leading market share in 2016, while the immunoprecipitation application segment’s market share is expected to reach 23.5%. Biopharmacuetical manufacturers will remain the prominent end-users of the global protein A resins, followed by clinical research labs and academic institutions.

Increasing number of clinical trials on biologics will continue to have a positive impact on protein A resins market in North America. The demand for protein A resins in APEJ region is expected to increase due to growing research on monoclonal antibodies in India and China.

Speak To Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1720

General Electric Company and Thermo Fisher Scientific Inc. are among the leading players in the global protein A resin market. Emerging players Merck Millipore and REPLIGEN CORP., are focusing on increasing market share by strategic collaborations, while expansion of product portfolio in life science and research catalogues remains a key business strategy for Novasep and GenScript.

Long-term Outlook: The global protein A resin market is expected to increase at a CAGR of 8.2% in terms of revenues during the forecast period 2016-2026. North America and APEJ will continue to be the leading markets during the forecast period.

North America is Most Lucrative Market for Optical Encoders

Rising demand for advanced automation systems will continue to positively impact global optical encoder market revenues. The global market, valued at US$ 1,357.4 Mn in 2015, is expected to register a y-o-y growth rate of 11.3 % and attain a market value worth US$ 1,464.5 Mn in 2016. Growing demand for high-quality assurance in surface mount technology (SMT) placement processes and increasing acceptance of advanced motion control systems will continue to drive the growth of the market.

The considerable rise in the implementation of advanced absolute encoders by the manufacturers of SMT placement equipment is providing favourable growth opportunities to manufacturers. Prominent industrial applications of optical encoders in elevators, medical diagnostics, robotics, and machine controls are serving as the primary factors leading to the expansion of the global optical encoders market. However, limitations related to complexity and delicate parts, and decreasing prices due to OEM pressures in developed economies are some of the key challenges restraining adoption of optical encoders.

On the basis of the output signal format, the global optical encoder market will witness a significant rise in the volumes of digital output optical encoders as they are expected to replace the existing analog optical encoders. In 2016, the digital output optical encoders segment is projected to reach 1,194.6 Mn in revenues.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1721

By configuration, the shafted-type optical encoders will continue to gain traction, and further its market share to 33% in 2016. Demand for hollow shaft type optical encoders, as well as absolute single turn and multi-turn encoders is also expected to witness steady growth in 2016 and beyond.

The use of optical encoders in healthcare equipment is expected to dominate the application-based segment of the global optical encoders market. The healthcare segment is expected to generate revenues of US$ 243.3 Mn by 2016-end. Application of optical encoders in consumer electronics, robotic and assembly equipment, as well as semiconductor manufacturing equipment is likely to augment the market size of the global optical encoders market.

By end-user, telecommunication and IT sector will continue to account for a significant share of global revenues, whereas space and aviation segment will remain the leading manufacturing end-user of the global optical encoders market.

North America will maintain its position as the most lucrative market for optical encoders, with total revenues expected to reach US$ 401.7 Mn in 2016. Adoption of optical encoders is expected to gain traction in Asia Pacific owing to rising adoption of smart devices and smart city incentives in India, South Korea, and China.

Speak To Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1721

Manufacturers will need to enhance production capacity and product quality to cater to the burgeoning demand for optical encoders. Rockwell Automation Inc. (Allen-Bradley), Sensata Technologies, Inc. (BEI Sensors), Renishaw PLC, Dynapar (Danaher Corporation), Allied Motion Technologies Inc., Codechamp SA, US Digital, Bourns Inc., GrayHill Inc., and Honeywell International Inc. are some of the key players driving the growth of the global market.

Long-term Outlook: The global optical encoder market is expected to increase at a CAGR of 8.7%, in terms of revenues, and 19.9%, in terms of volumes, during the forecast period 2016-2026. North America will account for the highest market share, while Asia Pacific will register market expansion at a CAGR of 8.8%.